Holen Sie sich die Stockscreener-App
0.00
100.00%
-14.84
Handel nachbörslich:
14.95
14.95
+
89 Bio Inc Aktie (ETNB) Neueste Nachrichten
Will 89bio Inc. stock go up in YEAR2025 Trade Ideas & AI Powered Buy/Sell Recommendations - mfd.ru
Is 89bio Inc. impacted by rising ratesDollar Strength & High Accuracy Trade Alerts - mfd.ru
Precision Trading with 89bio Inc. (ETNB) Risk Zones - Stock Traders Daily
Is 89bio Inc. stock attractive for ETFsProfit Target & Consistent Growth Equity Picks - bollywoodhelpline.com
Update Report: What is BSGMs revenue forecastMarket Rally & AI Powered Market Entry Strategies - baoquankhu1.vn
The Truth About 89bio Inc: Is This Silent Biotech Sleeper About To Explode? - AD HOC NEWS
Is 89bio Inc. stock supported by innovation pipelineEarnings Risk Report & Reliable Trade Execution Plans - ulpravda.ru
How 89bio Inc. stock compares to market leadersMarket Sentiment Report & Verified Momentum Stock Ideas - Улправда
Why 89bio Inc. stock attracts global investors2025 Momentum Check & Fast Gaining Stock Reports - Улправда
89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 104.68% Upside in the Biotech Sector - DirectorsTalk Interviews
Is 89bio Inc. stock dividend yield sustainableWeekly Risk Report & Verified Momentum Watchlists - ulpravda.ru
How 89bio Inc. stock compares to growth peers2025 Key Highlights & AI Powered Market Trend Analysis - Улправда
Aug Sectors: Is 89bio Inc. stock dividend yield sustainableWeekly Trade Report & Expert Curated Trade Setup Alerts - Улправда
Will 89bio Inc. stock recover faster than peersJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - Улправда
Downgrade Watch: How 89bio Inc. stock compares to growth peers2025 Macro Impact & Daily Risk Controlled Trade Plans - Улправда
[EFFECT] 89bio, Inc. SEC Filing - Stock Titan
89bio Acquisition Finalized: Roche Completes Takeover () - aktiencheck.de
[Form 4] 89bio, Inc. Insider Trading Activity - Stock Titan
Fatty liver disease companies' multibillion-dollar deals mean fatter wallets - The Business Journals
ETNB CEO Form 4 details Roche deal payout and option treatment - Stock Titan
ETNB officer reports tender offer completion; shares exchanged for $14.50 + CVR - Stock Titan
[POSASR] 89bio, Inc. SEC Filing - Stock Titan
Roche Holdings completes acquisition of 89bio and delists company from Nasdaq - Investing.com
Roche completes 89bio deal; ETNB holders get $14.50 cash + CVR - Stock Titan
89bio acquired by Roche with $14.50 cash and up to $6 CVR - Stock Titan
Roche purchases shares in tender offer for 89bio, Inc - The Manila Times
Roche (OTCQX: RHHBY) accepts 60.49% of 89bio shares, plans merger at $14.50 + CVR - Stock Titan
89bio, Inc.(NasdaqGM: ETNB) dropped from S&P Biotechnology Select Industry Index - MarketScreener
Roche Holding AG completed the acquisition of 89bio, Inc. in a tender offer transaction. - MarketScreener
ETNB CFO option exercises update direct holdings to 339,295 shares - Stock Titan
[SC TO-T/A] 89bio, Inc. Amended Third-Party Tender Offer | ETNB SEC FilingForm SC TO-T/A - Stock Titan
89bio, Inc. (ETNB) Stock Analysis: Exploring A Potential 97.97% Upside In Biotechnology - DirectorsTalk Interviews
Will 89bio Inc. stock split attract more investorsTrade Analysis Report & Safe Entry Zone Tips - Trung tâm Dự báo KTTV quốc gia
How strong is 89bio Inc. stock balance sheetEarnings Risk Summary & Fast Moving Stock Watchlists - Trung tâm Dự báo KTTV quốc gia
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (NasdaqETNB), Barinthus Biotherapeutics plc (NasdaqBRNS), Verint Systems Inc. (Nasdaq - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Combining price and volume data for 89bio Inc.Layoff News & Long-Term Growth Stock Strategies - newser.com
Will 89bio Inc. stock benefit from AI adoption2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
89bio, Inc. (ETNB) Stock Analysis: Unveiling A 97% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
Janus Henderson Reports 5,378,185 Shares, 3.6% Stake in 89bio - Stock Titan
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Investors Purchase High Volume of Put Options on 89BIO (NASDAQ:ETNB) - Defense World
After courting 14 pharmas, 89bio was left between a Roche and hard place in buyout talks - Fierce Biotech
Roche commences tender offer for all shares of 89bio, Inc. - GlobeNewswire
$20.50 Per Share Deal: Roche Makes Move to Acquire 89bio in Major Biotech Tender Offer - Stock Titan
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal - MSN
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash - Yahoo Finance
Kala Bio Stock Just Plunged 89% Today – Here’s What Happened - Stocktwits
Why 89bio Inc. stock is rated strong buy2025 Biggest Moves & Verified Entry Point Detection - newser.com
Technical analysis overview for 89bio Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is 89bio Inc. stock attractive for retirement portfoliosWeekly Stock Report & Momentum Based Trading Ideas - newser.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders - GlobeNewswire Inc.
Backtesting results for 89bio Inc. trading strategiesQuarterly Trade Review & Short-Term High Return Strategies - newser.com
2.90%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):